ORIGINAL RESEARCH ARTICLE
Year : 2021  |  Volume : 20  |  Issue : 1  |  Page : 82-91

Liquid chromatography–electro spray ionization–tandem mass spectroscopy method for the quantification of alogliptin in spiked human plasma


1 GITAM Institute of Pharmacy, GITAM (Deemed to be University), Visakhapatnam, Andhra Pradesh, India
2 Vaageswari Institute of Pharmaceutical Sciences, Ramakrishna Colony, Telangana, India

Correspondence Address:
PhD Sumanta Mondal
Associate Professor, GITAM Institute of Pharmacy, GITAM (Deemed to be University), Visakhapatnam, Andhra Pradesh 530045
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/epj.epj_55_20

Rights and Permissions

Background Alogliptin is the inhibitor of dipeptidyl peptidase-4. It acts to regulate blood sugar by increasing the amount of insulin in the body. Aim A liquid chromatography–mass spectroscopy/mass spectroscopy method was developed for the estimation of alogliptin in spiked human plasma. Liquid–liquid extraction technique was adopted for the extraction of alogliptin from human plasma. Materials and methods The chromatographic separation was performed on a Waters Symmetry shield RP C-18 column with 4.6-mm internal diameter, 5-μm particle size, 100A° pore size analytical column at a flow rate of 1.0 ml/min using a mixture of 0.3% formic acid and acetonitrile in the ratio of 20 : 80% v/v as mobile phase. Positive ion mode was selected to obtain the product ion m/z +339.19 (parent) →245.11 (product) for alogliptin and m/z +303.39 (parent) →232.16 (product) for internal standard. Results The developed method was satisfactorily validated as per United State Food and Drug Administration guidelines for the bioanalytical study because it exhibits excellent intraday and interday accuracy with % nominal 91.06→98.48% and precision percentage coefficient variation less than or equal to 2% in all quality control levels. Alogliptin revealed its linearity with correlation coefficient (r2=0.99) in the concentration range of 40.17–16 096 ng/ml, showed acceptable % extraction recovery (96.18→98.36%), and showed excellent matrix and analyte selectivity (% interference=0), as well as matrix effect (matrix factor 0.931 at lower quantitation limit and 1.14 at high quality control level). The stability study results of bench top, freeze thaw, autosampler, and short-term and long-term showed the accuracy in the range of 92.52–99.16% and percentage coefficient variation in the range of 0.22–1.93. Conclusion The method was successfully optimized and validated as per the United State Food and Drug Administration bioanalytical method development guidelines. The applicability of the developed method undoubtedly can further extend during preclinical and clinical trials.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed90    
    Printed0    
    Emailed0    
    PDF Downloaded28    
    Comments [Add]    

Recommend this journal